Top lists · Analyst moves
Analyst downgrades, July 2025
Quantisnow recorded 400 analyst downgrades in July 2025 across 300 companies. SRPT (Sarepta Therapeutics Inc.) had the most, with 10, followed by CNC (7) and REPL (7). The busiest day was Jul 14, 2025, with 31.
Sell-side rating cuts, newest first, with the firm and the new rating.
- Events
- 400
- Companies
- 300
- Busiest day
- Jul 14
- 31 that day
- Most frequent
- SRPT
- 10 events
Newest firsttop 100 of 400
- 01FTV
- 02ITW
- 03BRO
- 04CAR
- 05UNH
- 06CFLT
- 07CSL
- 08ZIMV
- 09VYNE
- 10VOD
- 11VFC
- 12TW
- 13TT
- 14SPSC
- 15LUNG
- 16PANW
- 17NVO
- 18LRCX
- 19CFLT
- 20ALGN
- 21AIN
- 22EDU
- 23RIO
- 24ENPH
- 25NXT
- 26NOV
- 27UPS
- 28NVO
- 29NEO
- 30BKNG
- 31BKR
- 32AMT
- 33ALB
- 34AMD
- 35UPS
- 36NEOG
- 37NEO
- 38WHR
- 39TPR
- 40PNR
- 41MEDP
- 42DOC
- 43DPZ
- 44CDNS
- 45ALB
- 46ADAP
- 47FIX
- 48PARA
- 49COIN
- 50TPH
- 51TTAM
- 52THC
- 53TECK
- 54SRPT
- 55RIOT
- 56PWR
- 57NTES
- 58IREN
- 59HCA
- 60HAL
- 61GEV
- 62GEV
- 63FCNCA
- 64CNM
- 65CSCO
- 66CNC
- 67BILI
- 68BHP
- 69AEO
- 70TECK
- 71ULTA
- 72TSLA
- 73TECK
- 74SYM
- 75SRPT
- 76RCKT
- 77PG
- 78PMT
- 79OSCR
- 80NVCR
- 81NSC
- 82MOH
- 83MOH
- 84HSIC
- 85DOW
- 86DB
- 87DAR
- 88AMP
- 89WBS
- 90PAGP
- 91PAA
- 92LUV
- 93T
- 94TMO
- 95MAG
- 96CME
- 97STM
- 98TTAM
- 99SAIA
- 100KEY
Year in review
Monthly archive
By sector (last 90 days)
Questions
- How many analyst downgrades were there in July 2025?
- Quantisnow recorded 400 analyst downgrades in July 2025 across 300 companies. SRPT (Sarepta Therapeutics Inc.) had the most, with 10, followed by CNC (7) and REPL (7). The busiest day was Jul 14, 2025, with 31.
- What is an analyst downgrade?
- A downgrade is a sell-side analyst lowering their rating on a stock, for example from Buy to Hold or from Outperform to Underperform. Downgrades are rarer than upgrades, which is why many traders weigh them more heavily.
- Why do analysts downgrade stocks?
- Common reasons are valuation after a strong run, slowing growth, a guidance cut, competitive pressure, or a change in the analyst's macro view. The research note usually spells out which one, and the headline typically names the firm and the new rating.